John McCamant - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock John McCamant's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
John McCamant

John McCamant

Verified

Editor, Medical Technology Stock Letter

San Francisco

Final Covers

psychotherapy, trauma burnout collective trauma,political polarization effective communication, the media and trauma second-hand trauma, PTSD conflict resolution, trauma healing

Doesn’t Cover

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 34

  • Top Picks 2025: Skye Bioscience (SKYE)

    By John McCamant

    Jan. 30, 2025

  • Top Picks 2025: Madrigal Pharmaceuticals (MDGL)

    By John McCamant

    Jan. 29, 2025

  • Top Picks 2025: Skye Bioscience (SKYE)

    By John McCamant

    Jan. 30, 2025

As seen in

Company Info

Medical Technology Stock Letter

For more than 30 years, the Medical Technology Stock Letter (MTSL) has provided independent investment advice based on rigorous analysis of emerging biotechnology companies and a unique perspective on industry fundamentals. MTSL has a proven track record of identifying many of today's industry leaders well before the consensus of other analysts.

San Francisco, , United States

+1 510-843-1857

Founded: